Hantavirus infection

Journal of the American Society of Nephrology

Volumn 16, Issue 12, 2005, Pages 3669-3679

  Muranyi, Walter ^a   Bahr, Udo ^a   Zeier, Martin ^a   Van Der Woude, Fokko J ^b  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHINESE DRUG; DNA VACCINE; HANTAVAX; HANTAVIRUS VACCINE; RIBAVIRIN; UNCLASSIFIED DRUG; VIRUS VACCINE;

CELLULAR IMMUNITY; CRUSH SYNDROME; CYTOKINE RELEASE; HANTAVIRUS; HANTAVIRUS PULMONARY SYNDROME; HEMORRHAGIC FEVER; HOST RANGE; HUMAN; HUMORAL IMMUNITY; INNATE IMMUNITY; KIDNEY DISEASE; LABORATORY DIAGNOSIS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; VIRUS INFECTION; VIRUS MORPHOLOGY; COMPARATIVE STUDY; FEMALE; HEALTH; HOSPITALIZATION; IMMUNOHISTOCHEMISTRY; INCIDENCE; ISOLATION AND PURIFICATION; MALE; PROGNOSIS; RISK ASSESSMENT; VIRUS HEMORRHAGIC FEVER;

FEMALE; HANTAVIRUS; HANTAVIRUS INFECTIONS; HANTAVIRUS PULMONARY SYNDROME; HEMORRHAGIC FEVER WITH RENAL SYNDROME; HUMANS; IMMUNOHISTOCHEMISTRY; INCIDENCE; MALE; PROGNOSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; WORLD HEALTH;

EID: 33645944393     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2005050561     Document Type: Review

References (117)

1. Bridson E: The English "sweate" (Sudor Anglicus) and Hantavirus pulmonary syndrome. Br J Biomed Sci 58: 1-6, 2001
2. McCaughey C, Hart CA: Hantaviruses. J Med Microbiol 49: 587-599, 2000
3. Johnson KM: Hantaviruses: History and overview. Curr Top Microbiol Immunol 256: 1-14, 2001
4. Smadel JE: Epidemic hemorrhagic fever. Am J Public Health 43: 1327-1330, 1953
5. Lee HW, Lee PW, Johnson KM: Isolation of the etiologic agent of Korean hemorrhagic fever. J Infect Dis 137: 298-308, 1978
6. Tidona CA, Darai G: The Springer Index of Viruses, Springer-Verlag, Berlin, 2002
7. van Regenmortel MHV, Fauquet CM, Bishop DHL, Carstens EB, Estes MK, Lemon SM, Maniloff J, Mayo MA, McGeoch DJ, Pringle CR, Wickner RB: Virus Taxonomy. Seventh Report of the International Committee on Taxonomy of Viruses, Academic Press, San Diego, 2000
8. Schmaljohn CS, Dalrymple JM: Analysis of Hantaan virus RNA: Evidence of a new genus of Bunyaviridae. Virology 131: 482-491, 1983
9. Plyusnin A, Vapalahti O, Vaheri A: Hantaviruses: Genome structure, expression and evolution. J Gen Virol 77: 2677-2687, 1996
10. Maes P, Clement J, Gavrilovskaya I, Van Ranst M: Hantaviruses: Immunology, treatment, and prevention. Viral Immunol 17: 481-497, 2004
11. Ulrich R, Hjelle B, Pitra C, Kruger DH: Emerging viruses: The case 'hantavirus.' Intervirology 45: 318-327, 2002
12. Nemirov K, Henttonen H, Vaheri A, Plyusnin A: Phylogenetic evidence for host switching in the evolution of hantaviruses carried by Apodemus mice. Virus Res 90: 207-215, 2002
13. Scharninghausen JJ, Faulde M, Cavaljuga S: Hantavirus host/virus interactions within Southeast Europe. Bosn J Basic Med Sci 4: 13-18, 2004
14. Weidmann M, Schmidt P, Vackova M, Krivanec K, Munclinger P, Hufert FT: Identification of genetic evidence for Dobrava virus spillover in rodents by nested reverse transcription (RT)-PCR and TaqMan RT-PCR. J Clin Microbiol 43: 808-812, 2005
15. Zeier M, Handermann M, Bahr U, Rensch B, Müller S, Kehm R, Muranyi W, Darai G: New ecological aspects of Hantavirus infection: A change of a paradigm and a challenge of prevention-A review. Virus Genes 30: 157-180, 2005
16. Plyusnin A, Morzunov SP: Virus evolution and genetic diversity of hantaviruses and their rodent hosts. Curr Top Microbiol Immunol 256: 47-75, 2001
17. Plyusnin A: Genetics of hantaviruses: Implications to taxonomy. Arch Virol 147: 665-682, 2002
18. Deutz A, Fuchs K, Schuller W, Nowotny N, Auer H, Aspock H, Stunzner D, Kerbl U, Klement C, Kofer J: Seroepidemiological studies of zoonotic infections in hunters in southeastern Austria-Prevalences, risk factors, and preventive methods. Berl Munch Tierarztl Wochenschr 116: 306-311, 2003
19. Zoller L, Faulde M, Meisel H, Ruh B, Kimmig P, Schelling U, Zeier M, Kulzer P, Becker C, Roggendorf M, et al.: Seroprevalence of hantavirus antibodies in Germany as determined by a new recombinant enzyme immunoassay. Eur J Clin Microbiol Infect Dis 14: 305-313, 1995
20. Vapalahti O, Mustonen J, Lundkvist A, Henttonen H, Plyusnin A, Vaheri A: Hantavirus infections in Europe. Lancet Infect Dis 3: 653-661, 2003
21. Hjelle B, Jenison S, Torrez-Martinez N, Yamada T, Nolte K, Zumwalt R, MacInnes K, Myers G: A novel hantavirus associated with an outbreak of fatal respiratory disease in the southwestern United States: Evolutionary relationships to known hantaviruses. J Virol 68: 592-596, 1994
22. Padula PJ, Edelstein A, Miguel SD, Lopez NM, Rossi CM, Rabinovich RD: Hantavirus pulmonary syndrome outbreak in Argentina: Molecular evidence for person-to-person transmission of Andes virus. Virology 241: 323-330, 1998
23. Pinna DM, Martinez VP, Bellomo CM, Lopez C, Padula P: New epidemiologic and molecular evidence of person to person transmission of hantavirus Andes Sout. Medicina (B Aires) 64: 43-46, 2004
24. Beers MH, Berkow R: Infectious diseases; Viral diseases. In: The Merck Manual of Diagnosis and Therapy, 17th Ed., Indianapolis, Wiley Publishers, 2005
25. Sirotin BZ, Keiser NP: On the history of the study of haemorrhagic fever with renal syndrome in eastern Russia. Nephrol Dial Transplant 16: 1288-1289, 2001
26. Makela S, Ala-Houhala I, Mustonen J, Koivisto AM, Kouri T, Turjanmaa V, Vapalahti O, Vaheri A, Pasternack A: Renal function and blood pressure five years after Puumala virus-induced nephropathy. Kidney Int 58: 1711-1718, 2000
27. Becker C, Goubeaud G, Zeier M, Zoller L: [Hantavirus infection and chronic renal failure]. Medizinische Welt 44: 569-573, 1993
28. Patnaik M, Velosa JA, Peter JB: Hantavirus-specific IgG, IgM, and IgA in acute and chronic renal disease versus congenital renal disease in the United States. Am J Kidney Dis 33: 734-737, 1999
29. Zeier M, Ritz E: [Hantavirus-induced acute renal failure]. Internist 37: 1092-1095, 1996
30. Zeier M, Zoller L, Haussmann W, Andrassy K, Ritz E: [The clinical picture and therapy of Hantaan virus infection]. Dtsch Med Wochenschr 115: 1678-1681, 1990
31. Mustonen J, Helin H, Pietila K, Brummer-Korvenkontio M, Hedman K, Vaheri A, Pasternack A: Renal biopsy findings and clinicopathologic correlations in nephropathia epidemica. Clin Nephrol 41: 121-126, 1994
32. Groen J, Bruijn JA, Gerding MN, Jordans JG, Moll van Charante AW, Osterhaus AD: Hantavirus antigen detection in kidney biopsies from patients with nephropathia epidemica. Clin Nephrol 46: 379-383, 1996
33. Death-Valley, US: Hantavirus: Technical information. Available: http://www.death-valley.us/hantall.html. Accessed June 2005
34. Cebalo L, Dusek T, Kuzman I, Markotic A: Grading the severity of disease in patients with Puumala or Dobrava virus infections from 1995 to 2000 in Croatia. Acta Med Croatica 57: 355-359, 2003
35. Mustonen J, Partanen J, Kanerva M, Pietila K, Vapalahti O, Pasternack A, Vaheri A: Genetic susceptibility to severe course of nephropathia epidemica caused by Puumala hantavirus. Kidney Int 49: 217-221, 1996
36. Plyusnin A, Horling J, Kanerva M, Mustonen J, Cheng Y, Partanen J, Vapalahti O, Kukkonen SK, Niemimaa J, Henttonen H, Niklasson B, Lundkvist A, Vaheri A: Puumala hantavirus genome in patients with nephropathia epidemica: Correlation of PCR positivity with HLA haplotype and link to viral sequences in local rodents. J Clin Microbiol 35: 1090-1096, 1997
37. Kilpatrick ED, Terajima M, Koster FT, Catalina MD, Cruz J, Ennis FA: Role of specific CD8+ T cells in the severity of a fulminant zoonotic viral hemorrhagic fever, hantavirus pulmonary syndrome. J Immunol 172: 3297-3304, 2004
38. Yanagihara R, Silverman DJ: Experimental infection of human vascular endothelial cells by pathogenic and non-pathogenic hantaviruses. Arch Virol 111: 281-286, 1990
39. Gavrilovskaya IN, Brown EJ, Ginsberg MH, Mackow ER: Cellular entry of hantaviruses which cause hemorrhagic fever with renal syndrome is mediated by beta3 integrins. J Virol 73: 3951-3959, 1999
40. Mackow ER, Gavrilovskaya IN: Cellular receptors and hantavirus pathogenesis. Curr Top Microbiol Immunol 256: 91-115, 2001
41. Kanerva M, Mustonen J, Vaheri A: Pathogenesis of Puumala and other hantavirus infections. Rev Med Virol 8: 67-86, 1998
42. Sundstrom JB, McMullan LK, Spiropoulou CF, Hooper WC, Ansari AA, Peters CJ, Rollin PE: Hantavirus infection induces the expression of RANTES and IP-10 without causing increased permeability in human lung microvascular endothelial cells. J Virol 75: 6070-6085, 2001
43. Kang JI, Park SH, Lee PW, Ahn BY: Apoptosis is induced by hantaviruses in cultured cells. Virology 264: 99-105, 1999
44. Li XD, Kukkonen S, Vapalahti O, Plyusnin A, Lankinen H, Vaheri A: Tula hantavirus infection of Vero E6 cells induces apoptosis involving caspase 8 activation. J Gen Virol 85: 3261-3268, 2004
45. Li XD, Lankinen H, Putkuri N, Vapalahti O, Vaheri A: Tula hantavirus triggers pro-apoptotic signals of ER stress in Vero E6 cells. Virology 333: 180-189, 2005
46. Markotic A, Hensley L, Geisbert T, Spik K, Schmaljohn C: Hantaviruses induce cytopathic effects and apoptosis in continuous human embryonic kidney cells. J Gen Virol 84: 2197-2202, 2003
47. Cosgriff TM, Lewis RM: Mechanisms of disease in hemorrhagic fever with renal syndrome. Kidney Int Suppl 35: S72-S79, 1991
48. Geimonen E, Neff S, Raymond T, Kocer SS, Gavrilovskaya IN, Mackow ER: Pathogenic and nonpathogenic hantaviruses differentially regulate endothelial cell responses. Proc Natl Acad Sci U S A 99: 13837-13842, 2002
49. Khaiboullina SF, Rizvanov AA, Deyde VM, St Jeor SC: Andes virus stimulates interferon-inducible MxA protein expression in endothelial cells. J Med Virol 75: 267-275, 2005
50. Kraus AA, Raftery MJ, Giese T, Ulrich R, Zawatzky R, Hippenstiel S, Suttorp N, Kruger DH, Schonrich G: Differential antiviral response of endothelial cells after infection with pathogenic and nonpathogenic hantaviruses. J Virol 78: 6143-6150, 2004
51. Linderholm M, Ahlm C, Settergren B, Waage A, Tarnvik A: Elevated plasma levels of tumor necrosis factor (TNF)-alpha, soluble TNF receptors, interleukin (IL)-6, and IL-10 in patients with hemorrhagic fever with renal syndrome. J Infect Dis 173: 38-43, 1996
52. Paakkala A, Mustonen J, Viander M, Huhtala H, Pasternack A: Complement activation in nephropathia epidemica caused by Puumala hantavirus. Clin Nephrol 53: 424-431, 2000
53. Khaiboullina SF, St Jeor SC: Hantavirus immunology. Viral Immunol 15: 609-625, 2002
54. Linderholm M, Bjermer L, Juto P, Roos G, Sandstrom T, Settergren B, Tarnvik A: Local host response in the lower respiratory tract in nephropathia epidemica. Scand J Infect Dis 25: 639-646, 1993
55. Bostik P, Winter J, Ksiazek TG, Rollin PE, Villinger F, Zaki SR, Peters CJ, Ansari AA: Sin nombre virus (SNV) Ig isotype antibody response during acute and convalescent phases of hantavirus pulmonary syndrome. Emerg Infect Dis 6: 184-187, 2000
56. Groen J, Gerding M, Jordans JG, Clement JP, Osterhaus AD: Class and subclass distribution of Hantavirus-specific serum antibodies at different times after the onset of nephropathia epidemica. J Med Virol 43: 39-43, 1994
57. Alexeyev OA, Ahlm C, Billheden J, Settergren B, Wadell G, Juto P: Elevated levels of total and Puumala virus-specific immunoglobulin E in the Scandinavian type of hemorrhagic fever with renal syndrome. Clin Diagn Lab Immunol 1: 269-272, 1994
58. Borish L, Williams J, Johnson S, Mascali JJ, Miller R, Rosenwasser LJ: Anti-inflammatory effects of nedocromil sodium: Inhibition of alveolar macrophage function. Clin Exp Allergy 22: 984-990, 1992
59. Clement J, McKenna P, Groen J, Osterhaus A, Colson P, Vervoort T, van der Groen G, Lee HW: Epidemiology and laboratory diagnosis of hantavirus (HTV) infections. Acta Clin Belg 50: 9-19, 1995
60. Lundkvist A, Horling J, Niklasson B: The humoral response to Puumala virus infection (nephropathia epidemica) investigated by viral protein specific immunoassays. Arch Virol 130: 121-130, 1993
61. Lewis RM, Lee HW, See AF, Parrish DB, Moon JS, Kim DJ, Cosgriff TM: Changes in populations of immune effector cells during the course of haemorrhagic fever with renal syndrome. Trans R Soc Trop Med Hyg 85: 282-286, 1991
62. de Carvalho Nicacio C, Sallberg M, Hultgren C, Lundkvist A: T-helper and humoral responses to Puumala hantavirus nucleocapsid protein: Identification of T-helper epitopes in a mouse model. J Gen Virol 82: 129-138, 2001
63. Van Epps HL, Schmaljohn CS, Ennis FA: Human memory cytotoxic T-lymphocyte (CTL) responses to Hantaan virus infection: Identification of virus-specific and cross-reactive CD8(+) CTL epitopes on nucleocapsid protein. J Virol 73: 5301-5308, 1999
64. Makela S, Mustonen J, Ala-Houhala I, Hurme M, Koivisto AM, Vaheri A, Pasternack A: Urinary excretion of interleukin-6 correlates with proteinuria in acute Puumala hantavirus-induced nephritis. Am J Kidney Dis 43: 809-816, 2004
65. Zaki SR, Greer PW, Coffield LM, Goldsmith CS, Nolte KB, Foucar K, Feddersen RM, Zumwalt RE, Miller GL, Khan AS, et al.: Hantavirus pulmonary syndrome. Pathogenesis of an emerging infectious disease. Am J Pathol 146: 552-579, 1995
66. Klingstrom J, Plyusnin A, Vaheri A, Lundkvist A: Wild-type Puumala hantavirus infection induces cytokines, C-reactive protein, creatinine, and nitric oxide in cynomolgus macaques. J Virol 76: 444-449, 2002
67. Temonen M, Mustonen J, Helin H, Pasternack A, Vaheri A, Holthofer H: Cytokines, adhesion molecules, and cellular infiltration in nephropathia epidemica kidneys: An immunohistochemical study. Clin Immunol Immunopathol 78: 47-55, 1996
68. Terajima M, Vapalahti O, Van Epps HL, Vaheri A, Ennis FA: Immune responses to Puumala virus infection and the pathogenesis of nephropathia epidemica. Microbes Infect 6: 238-245, 2004
69. Raftery MJ, Kraus AA, Ulrich R, Kruger DH, Schonrich G: Hantavirus infection of dendritic cells. J Virol 76: 10724-10733, 2002
70. Niikura M, Maeda A, Ikegami T, Saijo M, Kurane I, Morikawa S: Modification of endothelial cell functions by Hantaan virus infection: Prolonged hyper-permeability induced by TNF-alpha of Hantaan virus-infected endothelial cell monolayers. Arch Virol 149: 1279-1292, 2004
71. Kaukinen P, Vaheri A, Plyusnin A: Non-covalent interaction between nucleocapsid protein of Tula hantavirus and small ubiquitin-related modifier-1, SUMO-1. Virus Res 92: 37-45, 2003
72. Lee BH, Yoshimatsu K, Maeda A, Ochiai K, Morimatsu M, Araki K, Ogino M, Morikawa S, Arikawa J: Association of the nucleocapsid protein of the Seoul and Hantaan hantaviruses with small ubiquitin-like modifier-1-related molecules. Virus Res 98: 83-91, 2003
73. Li XD, Makela TP, Guo D, Soliymani R, Koistinen V, Vapalahti O, Vaheri A, Lankinen H: Hantavirus nucleocapsid protein interacts with the Fas-mediated apoptosis enhancer Da7x. J Gen Virol 83: 759-766, 2002
74. Gavrilovskaya IN, Shepley M, Shaw R, Ginsberg MH, Mackow ER: Beta3 Integrins mediate the cellular entry of hantaviruses that cause respiratory failure. Proc Natl Acad Sci U S A 95: 7074-7079, 1998
75. Gavrilovskaya IN, Peresleni T, Geimonen E, Mackow ER: Pathogenic hantaviruses selectively inhibit beta3 integrin directed endothelial cell migration. Arch Virol 147: 1913-1931, 2002
76. Raymond T, Gorbunova E, Gavrilovskaya IN, Mackow ER: Pathogenic hantaviruses bind plexin-semaphorin-integrin domains present at the apex of inactive, bent alphavbeta3 integrin conformers. Proc Natl Acad Sci U S A 102: 1163-1168, 2005
77. Geimonen E, LaMonica R, Springer K, Farooqui Y, Gavrilovskaya IN, Mackow ER: Hantavirus pulmonary syndrome-associated hantaviruses contain conserved and functional ITAM signaling elements. J Virol 77:1638-16343, 2003
78. Li Z, Bai X, Bian H: Serologic diagnosis of Hantaan virus infection based on a peptide antigen. Clin Chem 48: 645-647, 2002
79. Hujakka H, Koistinen V, Kuronen I, Eerikainen P, Parviainen M, Lundkvist A, Vaheri A, Vapalahti O, Narvanen A: Diagnostic rapid tests for acute hantavirus infections: Specific tests for Hantaan, Dobrava and Puumala viruses versus a hantavirus combination test. J Virol Methods 108: 117-122, 2003
80. Aitichou M, Saleh SS, McElroy AK, Schmaljohn C, Ibrahim MS: Identification of Dobrava, Hantaan, Seoul, and Puumala viruses by one-step real-time RT-PCR. J Virol Methods 124: 21-26, 2005
81. Moreli ML, Sousa RL, Figueiredo LT: Detection of Brazilian hantavirus by reverse transcription polymerase chain reaction amplification of N gene in patients with hantavirus cardiopulmonary syndrome. Mem Inst Oswaldo Cruz 99: 633-638, 2004
82. Huggins JW, Kim GR, Brand OM, McKee KT Jr: Ribavirin therapy for Hantaan virus infection in suckling mice. J Infect Dis 153: 489-497, 1986
83. Huggins JW, Hsiang CM, Cosgriff TM, Guang MY, Smith JI, Wu ZO, LeDuc JW, Zheng ZM, Meegan JM, Wang QN, et al.: Prospective, double-blind, concurrent, placebo-controlled clinical trial of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome. J Infect Dis 164: 1119-1127, 1991
84. Chapman LE, Mertz GJ, Peters CJ, Jolson HM, Khan AS, Ksiazek TG, Koster FT, Baum KF, Rollin PE, Pavia AT, Holman RC, Christenson JC, Rubin PJ, Behrman RE, Bell LJ, Simpson GL, Sadek RF; Ribavirin Study Group: Intravenous ribavirin for hantavirus pulmonary syndrome: Safety and tolerance during 1 year of open-label experience. Antivir Ther 4: 211-219, 1999
85. Chapman LE, Ellis BA, Koster FT, Sotir M, Ksiazek TG, Mertz GJ, Rollin PE, Baum KF, Pavia AT, Christenson JC, Rubin PJ, Jolson HM, Behrman RE, Khan AS, Bell LJ, Simpson GL, Hawk J, Holman RC, Peters CJ; Ribavirin Study Group: Discriminators between hantavirus-infected and -uninfected persons enrolled in a trial of intravenous ribavirin for presumptive hantavirus pulmonary syndrome. Clin Infect Dis 34: 293-304, 2002
86. Severson WE, Schmaljohn CS, Javadian A, Jonsson CB: Ribavirin causes error catastrophe during Hantaan virus replication. J Virol 77: 481-488, 2003
87. Jonsson CB, Milligan BG, Arterburn JB: Potential importance of error catastrophe to the development of antiviral strategies for hantaviruses. Virus Res 107: 195-205, 2005
88. Tamura M, Asada H, Kondo K, Takahashi M, Yamanishi K: Effects of human and murine interferons against hemorrhagic fever with renal syndrome (HFRS) virus (Hantaan virus). Antiviral Res 8: 171-178, 1987
89. Frese M, Kochs G, Feldmann H, Hertkorn C, Haller O: Inhibition of bunyaviruses, phleboviruses, and hantaviruses by human MxA protein. J Virol 70: 915-923, 1996
90. Kanerva M, Melen K, Vaheri A, Julkunen I: Inhibition of Puumala and tula hantaviruses in Vero cells by MxA protein. Virology 224: 55-62, 1996
91. Klingstrom J, Falk KI, Lundkvist A: Delayed viremia and antibody responses in Puumala hantavirus challenged passively immunized cynomolgus macaques. Arch Virol 150: 79-92, 2005
92. Custer DM, Thompson E, Schmaljohn CS, Ksiazek TG, Hooper JW: Active and passive vaccination against hantavirus pulmonary syndrome with Andes virus M genome segment-based DNA vaccine. J Virol 77: 9894-9905, 2003
93. Bai WT, Xu ZK, Zhang FL, Luo W, Liu Y, Wu XA, Yan Y: Transient expression and characterization of intracellular single chain Fv against the nucleocapsid protein of Hantavirus. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 20: 705-707, 2004
94. Smee DF, Sidwell RW, Huffman JH, Huggins JW, Kende M, Verbiscar AJ: Antiviral activities of tragacanthin polysaccharides on Punta Toro virus infections in mice. Chemotherapy 42: 286-293, 1996
95. Chu F, Ji Q, Yan RM, Wang XM, Pei B: A study on detecting specific antibodies of hemorrhagic fever with renal syndrome and treatment with integrated traditional Chinese and western medicine. Zhong Xi Yi Jie He Xue Bao 2: 20-23, 2004
96. Cho HW, Howard CR: Antibody responses in humans to an inactivated hantavirus vaccine (Hantavax). Vaccine 17: 2569-2575, 1999
97. Cho HW, Howard CR, Lee HW: Review of an inactivated vaccine against hantaviruses. Intervirology 45: 328-333, 2002
98. Hjelle B: Vaccines against hantaviruses. Expert Rev Vaccines 1: 373-384, 2002
99. Park K, Kim CS, Moon KT: Protective effectiveness of hantavirus vaccine. Emerg Infect Dis 10: 2218-2220, 2004
100. Sohn YM, Rho HO, Park MS, Kim JS, Summers PL: Primary humoral immune responses to formalin inactivated hemorrhagic fever with renal syndrome vaccine (Hantavax): Consideration of active immunization in South Korea Yonsei Med J 42: 278-284, 2001
101. Choi Y, Ahn CJ, Seong KM, Jung MY, Ahn BY: Inactivated Hantaan virus vaccine derived from suspension culture of Vero cells. Vaccine 21: 1867-1873, 2003
102. Hooper JW, Li D: Vaccines against hantaviruses. Curr Top Microbiol Immunol 256: 171-191, 2001
103. Dargeviciute A, Brus Sjolander K, Sasnauskas K, Kruger DH, Meisel H, Ulrich R, Lundkvist A: Yeast-expressed Puumala hantavirus nucleocapsid protein induces protection in a bank vole model. Vaccine 20: 3523-3531, 2002
104. Geldmacher A, Schmaler M, Kruger DH, Ulrich R: Yeast-expressed hantavirus Dobrava nucleocapsid protein induces a strong, long-lasting, and highly cross-reactive immune response in mice. Viral Immunol 17: 115-122, 2004
105. Kehm R, Jakob NJ, Welzel TM, Tobiasch E, Viczian O, Jock S, Geider K, Sule S, Darai G: Expression of immunogenic Puumala virus nucleocapsid protein in transgenic tobacco and potato plants. Virus Genes 22: 73-83, 2001
106. Khattak S, Darai G, Rosen-Wolff A: Puumala virus nucleo-capsid protein expressed in transgenic plants is not immunogenic after oral administration. Virus Genes 29: 109-116, 2004
107. Klingstrom J, Maljkovic I, Zuber B, Rollman E, Kjerrstrom A, Lundkvist A: Vaccination of C57/BL6 mice with Dobrava hantavirus nucleocapsid protein in Freund's adjuvant induced partial protection against challenge. Vaccine 22: 4029-4034, 2004
108. Geldmacher A, Skrastina D, Petrovskis I, Borisova G, Berriman JA, Roseman AM, Crowther RA, Fischer J, Musema S, Gelderblom HR, Lundkvist A, Renhofa R, Ose V, Kruger DH, Pumpens P, Ulrich R: An amino-terminal segment of hantavirus nucleocapsid protein presented on hepatitis B virus core particles induces a strong and highly cross-reactive antibody response in mice. Virology 323: 108-119, 2004
109. Ulrich R, Koletzki D, Lachmann S, Lundkvist A, Zankl A, Kazaks A, Kurth A, Gelderblom HR, Borisova G, Meisel H, Kruger DH: New chimaeric hepatitis B virus core particles carrying hantavirus (serotype Puumala) epitopes: Immunogenicity and protection against virus challenge. J Biotechnol 73: 141-153, 1999
110. Chu YK, Jennings GB, Schmaljohn CS: A vaccinia virus-vectored Hantaan virus vaccine protects hamsters from challenge with Hantaan and Seoul viruses but not Puumala virus. J Virol 69: 6417-6423, 1995
111. Schmaljohn CS, Chu YK, Schmaljohn AL, Dalrymple JM: Antigenic subunits of Hantaan virus expressed by baculo-virus and vaccinia virus recombinants. J Virol 64: 3162-3170, 1990
112. Yoshimatsu K, Yoo YC, Yoshida R, Ishihara C, Azuma I, Arikawa J: Protective immunity of Hantaan virus nucleocapsid and envelope protein studied using baculovirus-expressed proteins. Arch Virol 130: 365-376, 1993
113. McClain DJ, Summers PL, Harrison SA, Schmaljohn AL, Schmaljohn CS: Clinical evaluation of a vaccinia-vectored Hantaan virus vaccine. J Med Virol 60: 77-85, 2000
114. Bharadwaj M, Lyons CR, Wortman IA, Hjelle B: Intramus-cular inoculation of Sin Nombre hantavirus cDNAs induces cellular and humoral immune responses in BALB/c mice. Vaccine 17: 2836-2843, 1999
115. Hooper JW, Kamrud KI, Elgh F, Custer D, Schmaljohn CS: DNA vaccination with hantavirus M segment elicits neutralizing antibodies and protects against Seoul virus infection. Virology 255: 269-278, 1999
116. Hooper JW, Custer DM, Thompson E, Schmaljohn CS: DNA vaccination with the Hantaan virus M gene protects Hamsters against three of four HFRS hantaviruses and elicits a high-titer neutralizing antibody response in Rhesus monkeys. J Virol 75: 8469-8477, 2001
117. Koletzki D, Schirmbeck R, Lundkvist A, Meisel H, Kruger DH, Ulrich R: DNA vaccination of mice with a plasmid encoding Puumala hantavirus nucleocapsid protein mimics the B-cell response induced by virus infection. J Biotechnol 84: 73-78, 2001